Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$138.42 - $180.31 $160,428 - $208,979
-1,159 Reduced 37.88%
1,901 $268,000
Q1 2023

May 15, 2023

BUY
$154.26 - $198.1 $472,035 - $606,186
3,060 New
3,060 $515,000
Q4 2020

Feb 16, 2021

SELL
$148.08 - $206.57 $306,525 - $427,599
-2,070 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$122.51 - $158.27 $253,595 - $327,618
2,070 New
2,070 $305,000
Q4 2019

Feb 14, 2020

SELL
$73.84 - $93.08 $217,311 - $273,934
-2,943 Closed
0 $0
Q3 2019

Nov 08, 2019

BUY
$76.65 - $95.51 $225,580 - $281,085
2,943 New
2,943 $226,000
Q2 2019

Aug 12, 2019

SELL
$54.2 - $85.95 $199,022 - $315,608
-3,672 Closed
0 $0
Q1 2019

Apr 29, 2019

SELL
$49.45 - $62.8 $85,251 - $108,267
-1,724 Reduced 31.95%
3,672 $217,000
Q4 2018

Jan 28, 2019

BUY
$48.26 - $68.88 $260,410 - $371,676
5,396 New
5,396 $285,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $9.21B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Quantamental Technologies LLC Portfolio

Follow Quantamental Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantamental Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantamental Technologies LLC with notifications on news.